Methods of using dmt
OwnerWilliam Shulmaninventor
Life of this patent
Estimating the term…
Abstract
The present disclosure relates in some aspects to methods for modulating and improving the subjective experience of N,N-dimethyltryptamine (DMT) by administering DMT after a long-acting tryptamine such as psilacetin, and in some embodiments, together with a benzodiazepine and/or ketamine, or in some further embodiments, together with a second long-acting psychedelic. In some aspects, disclosed methods are useful for treating medical conditions, such as mental health disorders and neurodegenerative disorders. In some aspects, disclosed methods are useful for improving health and wellbeing, such as in healthy people.
Claims28
A method of improving an individual's subjective experience of DMT, comprising administering to the individual:
- i. a long-acting tryptamine, or a pharmaceutically acceptable salt thereof;
- and
- ii. DMT, or a pharmaceutically acceptable salt thereof;
- wherein administering the long-acting tryptamine is prior to administering the DMT.
A method of improving an individual's subjective experience of DMT, comprising administering to the individual:
- i. psilacetin, or a pharmaceutically acceptable salt thereof;
- ii. DMT, or a pharmaceutically acceptable salt thereof;
- iii. lorazepam, or a pharmaceutically acceptable salt thereof;
- and
- iv. ketamine, or a pharmaceutically acceptable salt thereof;
- wherein administering the psilacetin is prior to administering the DMT;
- and wherein the individual's subjective experience of DMT is improved in at least one respect compared to the administration of an equal amount of DMT alone.
Dependencies are inferred from the claim text.